Ferritin in autoimmune diseases

Autoimmunity Reviews

Volumn 6, Issue 7, 2007, Pages 457-463

  Zandman Goddard, Gisele ^a   Shoenfeld, Yehuda ^b  

^a Wolfson Medical Center   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Dermatomyositis; Ferritin; Multiple sclerosis; Polymyositis; Rheumatoid arthritis; Systemic lupus erythematosus; Thyroiditis

Indexed keywords

CYTOKINE; FERRITIN; FERRITIN H; FERRITIN L; FREE RADICAL; HORMONE; INSULIN; IRON; PROTEIN SUBUNIT; SOMATOMEDIN C; THYROID HORMONE; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CANCER; CATARACT; CELL FUNCTION; CYTOKINE PRODUCTION; DERMATOMYOSITIS; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; GENE MUTATION; GENETIC TRANSCRIPTION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; IMMUNE RESPONSE; INFECTION; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; MULTIPLE SCLEROSIS; NEUROFERRITINOPATHY; NEUROPATHY; OXIDATIVE STRESS; POLYMYOSITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROIDITIS;

ANEMIA; AUTOIMMUNE DISEASES; FERRITINS; GENE EXPRESSION REGULATION; HUMANS;

EID: 34447559573     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.016     Document Type: Review

References (36)

1. Hintze K.J., and Theil E.C. Cellular regulation and molecular interactions of the ferritins. Cell Mol Life Sci 63 (2006) 591-600
2. Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann NY Acad Sci 1012 (2004) 1-13
3. Torti F.M., and Torti S.V. Regulation of ferritin genes and protein. Blood 99 (2002) 3505-3516
4. Zandman-Goddard G., Blank M., Langevitz P., Slutsky L., Pras M., Levy Y., et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis 64 (2005) 1698-1702
5. You S.A., and Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 357 (2005) 1-16
6. Nishiya K., and Hashimoto K. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Clin Exp Rheumatol 15 (1997) 39-44
7. Morikawa K., Oseko F., and Morikawa S. H and L-rich ferritins suppress antibody production, but not proliferation of human B lymphocytes in vitro. Blood 83 (1994) 737-743
8. Hann H.W.L., Stahlhut M.W., Lee S., London W.T., and Hann R.S. Effects of isoferritins on human granulocytes. Cancer 63 (1989) 2492-2496
9. Broxmeyer H.E., Bognacki J., Dorner M.H., and De Sousa M. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med 153 (1981) 1426-1444
10. Linert W., and Jameson G.N.L. Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's disease. J Inorg Biochem 79 (2000) 319-326
11. Kondo T., Shirasawa T., Itoyama Y., and Mori H. Embryonic genes expressed in Alzheimer's disease. Neurosci Lett 209 (1996) 157-160
12. Ryan T.P., Krzesicki R.F., Blakeman D.P., Chin J.E., Griffins R.L., Ruchards I.M., et al. Pulmonary ferritin: differential effects of hyperoxic lung injury on subunit mRNA levels. Free Radic Biol Med 22 (1997) 901-908
13. Beaumont C., Leneuve P., Devaux I., Scoazec J.Y., Berthier M., Loiseau M.N., et al. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinemia and cataract. Nat Genet 11 (1995) 444-446
14. Curtis A.R.J., Fey C., Morris C.M., Bindoff L.A., Chinnery I.P.G., et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28 (2001) 350-354
15. Rasmussen M.L., Folsom A.R., Catellier D.J., Tsai M.Y., Garg U., and Eckfeldt J.H. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154 (2001) 739-746
16. Zandman-Goddard G., Matzner Y., Konijn A.M., and Hershko C. Cerebrospinal fluid ferritin in malignant CNS involvement. Cancer 58 (1986) 1346-1349
17. Uppal S.S., Al-Mutairi M., Hayat S., Abraham M., and Malayiya A. Ten years of clinical experience with adult onset Still's disease: is the outcome improving?. Clin Rheumatol (2006) [epub ahead of print]
18. Choi J.H., Suh C.H., Lee Y.M., Suh Y.J., Lee S.K., Kim S.S., et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 30 (2003) 2422-2427
19. Arlet J.B., le T.H., Marinho A., Amoura Z., Wechsler B., Papo T., and Piette J.C. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 65 (2006) 1596-1601
20. Coffernils M., Soupart A., Pradier O., Feremans W., Neve P., and Decaux G. Hyperferritinemia in adult-onset Still's disease and the hemophagocytic syndrome. J Rheumatol 19 (1992) 1425-1427
21. van-Reeth C., Moel G.L., Lasne Y., Revenant M.C., Agneray J., Kahn M.F., et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol 21 (1994) 890-895
22. Blake D.R., Bacon P.A., Eastham E.J., and Brigham K. Synovial fluid ferritin in rheumatoid arthritis. Br Med J 281 (1980) 715-716
23. Muirden K.D. Ferritin in synovial cells in patients with rheumatoid arthritis. Ann Rheum Dis 25 (1966) 387-401
24. Pelkonen P., Swanjung K., and Siimes M.A. Ferritinemia as an indicator of systemic disease activity in children with systemic juvenile rheumatoid arthritis. Acta Paediatr Scand 75 (1986) 64-68
25. Yildirim K., Karatay S., Melikoglu M.A., Gureser G., Ugur M., and Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 34 (2004) 423-426
26. Nishiya K., Kawabata F., and Ota Z. Elevated urinary ferritin in lupus nephritis. J Rheumatol 16 (1989) 1513-1514
27. Lim M.K., Lee C.K., Ju Y.S., Cho Y.S., Lee M.S., Yoo B., et al. Serum ferritin as a serological marker of activity in systemic lupus erythematosus. Rheumatol Int 20 (2001) 89-93
28. Beyan E., Beyan C., Demirezer A., Ertugrul E., and Uzuner A. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus. Scand J Rheumatol 32 (2003) 225-228
29. Hesselink D.A., Aarden L.A., and Swak A.J.G. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus. Scand J Rheumatol 32 (2003) 151-155
30. Levine S.M., and Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 1012 (2004) 252-266
31. LeVine S.M., Maiti S., Emerson M.R., and Pedchenko T.V. Apoferritin attenuates experimental allergic encephalomyelitis in SJL mice. Dev Neurosci 24 (2002) 177-183
32. Hulet S.W., Powers S., and Connor J.R. Distribution of transferring and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci 165 (1999) 48-55
33. Sfagos C., Makis A.C., Chaidos A., Hatzimichael E.C., Dalamaga A., Kosma K., et al. Serum ferritin, transferrin and soluble transferring receptor levels in multiple sclerosis patients. Mult Scler 11 (2005) 272-275
34. LeVine S.M., Lynch S.G., Ou C.N., Wulser M.J., Tam E., and Boo N. Ferritin, transferring and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients. Brain Res 821 (1999) 511-515
35. Sakata S., Nagai K., Maekawa H., Kimata Y., Komaki T., Nakamura S., et al. Serum ferritin concentration in subacute thyroiditis. Metabolism 40 (1991) 683-688
36. Marie I., Hatron P.Y., Levesque H., Hachulla E., Hellot M.F., Michon-Pasturel U., et al. Influence of age on characteristic of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 78 (1999) 139-147